AI & quantum capabilities across drug discovery.
Eight capabilities that span the discovery lifecycle — from target discovery and generative design to quantum molecular simulation and precision medicine — unified in one AI-native platform.
AI-Powered Target Discovery
Machine learning and multi-omics intelligence identify and rank novel therapeutic targets from genomic, proteomic, transcriptomic, and clinical data — so teams pursue the biology most likely to matter.
Quantum Molecular Simulation
Quantum computing models protein-ligand interactions and complex chemical systems with accuracy beyond classical methods — letting researchers explore promising candidates more efficiently.
Generative Drug Design
Generative AI designs novel small molecules and optimizes compounds for potency, selectivity, pharmacokinetics, and safety — expanding the design space without expanding the bench work.
Virtual Screening at Scale
AI-powered predictive models rapidly evaluate millions of compounds to surface the most promising therapeutic candidates — significantly reducing laboratory screening effort.
Predictive ADMET & Toxicity
Predict absorption, distribution, metabolism, excretion, toxicity, and efficacy early in discovery — reducing the costly downstream failures that derail programs.
Scientific Knowledge Intelligence
Continuously analyze publications, patents, clinical trials, biomedical databases, and proprietary research to uncover hidden relationships, surface emerging opportunities, and support evidence-based decisions.
AI Research Agents
Specialized AI agents collaborate across literature review, hypothesis generation, target validation, molecule optimization, biomarker discovery, competitive intelligence, and portfolio analysis — freeing researchers to focus on innovation.
Precision Medicine Intelligence
Integrate genomic, clinical, and biomarker data to identify patient subgroups and support the development of personalized therapies — connecting discovery to the right populations.
See a capability on your data.
Pick the discovery challenge that matters most — targets, screening, design, or simulation — and we'll scope a focused pilot with measurable impact.